Biochemical Characterization of IMP-30, a Metallo-β-Lactamase with Enhanced Activity toward Ceftazidime

Por Pegg, Kevin M., Liu, Eleanor M., LaCuran, Alecander E., Oelschlaeger, Peter
Publicado em 2013

Uncovering Molecular Bases Underlying Bone Morphogenetic Protein Receptor Inhibitor Selectivity

Por Alsamarah, Abdelaziz, LaCuran, Alecander E., Oelschlaeger, Peter, Hao, Jijun, Luo, Yun
Publicado no PLoS One (2015)

New β-phospholactam as a carbapenem transition state analog: synthesis of a broad-spectrum inhibitor of metallo-β-lactamases

Por Yang, Ke-Wu, Feng, Lei, Yang, Shao-Kang, Aitha, Mahesh, LaCuran, Alecander E., Oelschlaeger, Peter, Crowder, Michael W.
Publicado em 2013

Understanding the determinants of substrate specificity in IMP family metallo-β-lactamases: The importance of residue 262

Por Pegg, Kevin M, Liu, Eleanor M, George, Alex C, LaCuran, Alecander E, Bethel, Christopher R, Bonomo, Robert A, Oelschlaeger, Peter
Publicado no Protein Sci (2014)

Elucidating the Role of Residue 67 in IMP-Type Metallo-β-Lactamase Evolution

Por LaCuran, Alecander E., Pegg, Kevin M., Liu, Eleanor M., Bethel, Christopher R., Ai, Ni, Welsh, William J., Bonomo, Robert A., Oelschlaeger, Peter
Publicado no Antimicrob Agents Chemother (2015)